KEYTRUDA QLEX FDA approval date

The FDA approved KEYTRUDA QLEX on 19 Sep 2025.

FDA approval date
19 Sep 2025

Drug identity has not yet been verified against registry records

Also recorded as BERAHYALURONIDASE ALFA-PMPH; PEMBROLIZUMAB

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2025-09-19DayKEYTRUDA QLEXFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761467", "applicant_as_listed_by_fda": "MERCK SHARP DOHME", "brand_names": ["KEYTRUDA QLEX"], "active_ingredients": ["BERAHYALURONIDASE ALFA-PMPH", "PEMBROLIZUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20250919", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026